全文获取类型
收费全文 | 114374篇 |
免费 | 10779篇 |
国内免费 | 8157篇 |
专业分类
耳鼻咽喉 | 1043篇 |
儿科学 | 1226篇 |
妇产科学 | 1194篇 |
基础医学 | 13240篇 |
口腔科学 | 2505篇 |
临床医学 | 15345篇 |
内科学 | 16443篇 |
皮肤病学 | 1029篇 |
神经病学 | 5729篇 |
特种医学 | 4204篇 |
外国民族医学 | 66篇 |
外科学 | 11076篇 |
综合类 | 21187篇 |
现状与发展 | 36篇 |
一般理论 | 4篇 |
预防医学 | 7647篇 |
眼科学 | 3169篇 |
药学 | 11828篇 |
101篇 | |
中国医学 | 6803篇 |
肿瘤学 | 9435篇 |
出版年
2024年 | 413篇 |
2023年 | 1930篇 |
2022年 | 4596篇 |
2021年 | 5721篇 |
2020年 | 4390篇 |
2019年 | 3719篇 |
2018年 | 3827篇 |
2017年 | 3630篇 |
2016年 | 3269篇 |
2015年 | 5271篇 |
2014年 | 6387篇 |
2013年 | 5823篇 |
2012年 | 8629篇 |
2011年 | 9577篇 |
2010年 | 6155篇 |
2009年 | 4990篇 |
2008年 | 6089篇 |
2007年 | 6435篇 |
2006年 | 6074篇 |
2005年 | 6022篇 |
2004年 | 3782篇 |
2003年 | 3531篇 |
2002年 | 3032篇 |
2001年 | 2570篇 |
2000年 | 2659篇 |
1999年 | 2819篇 |
1998年 | 1839篇 |
1997年 | 1737篇 |
1996年 | 1313篇 |
1995年 | 1153篇 |
1994年 | 967篇 |
1993年 | 640篇 |
1992年 | 751篇 |
1991年 | 650篇 |
1990年 | 580篇 |
1989年 | 504篇 |
1988年 | 424篇 |
1987年 | 376篇 |
1986年 | 269篇 |
1985年 | 209篇 |
1984年 | 108篇 |
1983年 | 87篇 |
1982年 | 51篇 |
1981年 | 54篇 |
1980年 | 40篇 |
1979年 | 56篇 |
1976年 | 13篇 |
1974年 | 12篇 |
1972年 | 14篇 |
1968年 | 13篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
51.
52.
53.
S. Xing X. Zhang J. H. Liu X. Huang P. Zhou 《Clinical and experimental immunology》2019,195(1):121-131
Recent experimental strategies to reduce graft-versus-host disease (GVHD) have focused largely on modifying innate immunity. Toll-like receptor (TLR)-driven myeloid differentiation primary response 88 (MyD88)-dependent signalling pathways that initiate adaptive immune function are also critical for the pathogenesis of GVHD. This study aimed to delineate the role of host MyD88 in the development of acute GVHD following fully major histocompatibility complex-mismatched allogeneic bone marrow transplantation (BMT). When myeloablated BALB/c MyD88 knock-out recipients were transplanted with C57BL/6 (B6) donor cells, they developed significantly more severe GVHD than wild-type (WT) BALB/c hosts. The increased morbidity and mortality in MyD88–/– mice correlated with increased serum levels of lipopolysaccharide and elevated inflammatory cytokines in GVHD target organs. Additionally, MyD88 deficiency in BMT recipients led to increased donor T cell expansion and more donor CD11c+ cell intestinal infiltration with apoptotic cells but reduced proliferation of intestinal epithelial cells compared with that in WT BMT recipients. Decreased expression of tight junction mRNA in epithelial cells of MyD88–/– mice suggested that MyD88 contributes to intestinal integrity. Cox-2 expression in the GVHD-targeted organs of WT mice is increased upon GVHD induction, but this enhanced expression was obviously inhibited by MyD88 deficiency. The present findings demonstrate an unexpected role for host MyD88 in preventing GVHD after allogeneic BMT. 相似文献
54.
55.
当利用放射线对胸部恶性肿瘤进行治疗时,位于纵隔的心脏会不可幸免受到照射,从而诱发放射性心脏损伤(radiation-induced heart disease, RIHD)。随着手术以及放化疗技术的提升,肿瘤患者生存时间得到延长,使得RIHD这一放疗远期并发症被越来越多的报道。因此,学者们对于RIHD的研究逐渐升温。目前国内外学者关于该疾病尚未形成统一的认识,临床上缺乏有效阻止其发生的方法。动物模型研究可为临床该疾病治疗及预防提供可靠证据,为此本文回顾分析近年来放射性心脏损伤动物模型实验研究情况,旨在为后续实验开展及临床应用提供参考。 相似文献
56.
57.
58.
59.
Zhengxian Huang Nan Xie Haichao Liu Yuehan Wan Yue Zhu Ming Zhang Yifan Tao Han Zhou Xiqiang Liu Jinsong Hou Cheng Wang 《Journal of oral pathology & medicine》2019,48(9):788-798
It has been suggested that tumour‐infiltrating lymphocytes (TILs) are associated with the progression of oral squamous cell carcinoma (OSCC). However, the prognostic value of TILs is inconclusive due to the heterogeneity of immune cells within the tumour microenvironment. In this meta‐analysis, we aimed to assess the prognostic value of TILs in OSCC. The PubMed, Cochrane, Embase, Scopus and Web of Science databases were searched up to April 20, 2019, and 33 studies were ultimately included in this meta‐analysis. Our pooled meta‐analysis showed that high infiltration of CD8+ TILs, CD45RO+ TILs and CD57+ TILs favoured better overall survival (OS). However, high infiltration of CD68+ macrophages and CD163+ macrophages was associated with poor prognosis in OSCC. These findings suggest that CD8+ TILs, CD45RO+ TILs, CD57+ TILs, CD68+ macrophages and CD163+ macrophages might serve as novel prognostic factors and therapeutic targets in OSCC. 相似文献